Search

Your search keyword '"Rizzetto, M."' showing total 394 results

Search Constraints

Start Over You searched for: Author "Rizzetto, M." Remove constraint Author: "Rizzetto, M." Journal journal of hepatology Remove constraint Journal: journal of hepatology
394 results on '"Rizzetto, M."'

Search Results

7. Portal Vein Thrombosis Relevance on Liver Cirrhosis: Italian Venous Thrombotic Events Registry

11. Diversity of clinical presentation and virological characteristics of hepatitis delta in different regions world-wide: results of the Hepatitis Delta International network

12. Markedly improvement of glycaemic control in diabetic patients with chronic hepatitis C achieving sustained virologic response after direct acting antiviral therapy: results of a prospective controlled study

14. Declining prevalence and increasing awareness of hepatitis C virus infection in Italy: a population-based survey

15. High Efficacy of Ledipasvir/Sofosbuvir Plus Ribavirin among Patients with Decompensated Cirrhosis who Underwent Liver Transplant during Participation in the Solar-1 and -2 Studies

16. Analysis of Hemodynamic Effects of Bosentan on Portopulmonary Hypertension in Short-Term and Medium-Term Follow-Up: Promising Predictors of Response to Therapy?

20. All Oral Sofosbuvir-Based Antiviral Therapy in Liver Transplant Recipients Affected by Moderate-Severe Hepatitis C Recurrence: Predictors of Viral Response and Survival

23. P1056 : Insulin resistance and liver damage are associated with early signs of left ventricular systolic dysfunction in patients with nonalcoholic fatty liver disease, independently of diabetes, hypertension and dyslipidemia

24. P1058 : Increased epicardial fat and early signs of impaired diastolic and systolic left ventricular function in non-diabetic, non-dyslipidemic, normotensive patients with Nonalcoholic Fatty Liver Disease

26. P0519 : Lipidomics reveals that low plasma unsaturated to saturated fat ratios are biomarkers of NAFLD and liver damage

27. P1042 : Deregulation of de novo lipogenesis can be associated with liver damage in patients with non alcoholic fatty liver disease

28. P0069 : Risk factors for metabolic syndrome after liver transplantation: What has changed over time

30. P0060 : Antiviral therapy with sofosbuvir plus ribavirin in HCV-infected cirrhotic patients awaiting liver transplantation: Preliminary data from a single-centre experience

31. P0063 : Sofosbuvir plus ribavirin for the treatment of severe hcv recurrence after liver transplantation: Preliminary data from a single-centre experience

32. P843 ALTERATION IN GLUCOSE METABOLISM AFTER AN ORAL GLUCOSE LOAD AND RELATIONSHIP WITH LIVER DAMAGE IN PATIENTS WITH NAFLD

33. P1028 NON-INVASIVE SCORE SYSTEM FOR FIBROSIS (NISF) IN CHRONIC LIVER DISEASE: A NEW MODEL COMBINING BIOCHEMICAL, ELASTOGRAPHIC AND ULTRASOUND DATA

34. P1209 FACTORS INFLUENCING RENAL FUNCTION IN PATIENTS RECEIVING TELAPREVIR TWICE DAILY OR EVERY 8 HOURS: RESULTS FROM THE PHASE III OPTIMIZE STUDY

35. P845 IMPACT OF FAT VERSUS GLUCOSE LOAD ON OXIDATIVE STRESS IN NON-ALCOHOLIC FATTY LIVER DISEASE

38. P995 SORAFENIB VERSUS Y-RADIOEMBOLIZATION FOR ADVANCED MONO-LOBAR HEPATOCELLULAR CARCINOMA IN CIRRHOTIC PATIENTS: A PRELIMINARY STUDY ON TOLERABILITY AND SURVIVAL

40. P1158 EFFICACY AND SAFETY OF BOCEPREVIR-BASED THERAPY IN HCVG1 TREATMENT-EXPERIENCED PATIENTS WITH ADVANCED FIBROSIS/CIRRHOSIS: THE ITALIAN AND SPANISH NPP EARLY ACCESS PROGRAM

42. P849 QUANTITATIVE AND QUALITATIVE ANALYSIS OF PLASMA FREE FATTY ACIDS AND THEIR IMPACT ON LIVER DAMAGE IN NAFLD PATIENTS

43. P840 ALTERATION IN LIPID METABOLISM AFTER AN ORAL FAT LOAD IN PATIENTS WITH NAFLD

44. SAT-119 - High Efficacy of Ledipasvir/Sofosbuvir Plus Ribavirin among Patients with Decompensated Cirrhosis who Underwent Liver Transplant during Participation in the Solar-1 and -2 Studies

50. 919 ANEMIA AND ITS MANAGEMENT IN PATIENTS TREATED WITH TELAPREVIR TWICE DAILY VERSUS EVERY 8 HOURS IN THE PHASE III OPTIMIZE STUDY

Catalog

Books, media, physical & digital resources